Fostering a Culture of Health Innovation: A Review of Regulation and Integration of AI, Genomics, and Digital Therapeutics by the Ministry of Health

Background: The global health landscape is being redefined by a new era of emerging technologies, including artificial intelligence (AI), genomics, and digital therapeutics (DTx). The technologies hold the promise to shift healthcare from an episodic, reactive, and hospital-based system to a predictive, personalized, and participatory system. However, their incorporation in healthcare systems raises severe problems for regulation, ethics, equity, and implementation. The national Ministry of Health (MoH) is at the center of coordinating this transition, but its role must change beyond traditional roles such that it actively encourages a culture of responsible innovation. Aim: The purpose of this narrative review is to synthesize existing literature for critically analyzing the multidimensional role of the MoH in spearheading the integration of AI, genomics, and DTx. Methods: Systematic peer-reviewed and grey literature search between 2010-2024 on PubMed, Scopus, Web of Science, and WHO, FDA, and other regulatory sources. Thematic analysis with results structured around three core domains: governance, infrastructure, and adoption. Results: The review suggests that holistic strategies are necessary for successful integration. In regulation, MoHs must implement flexible, risk-appropriate regulatory frameworks for adaptive AI and DTx that ensure ethical exploitation of genomic information. State investment in underlying infrastructure, such as national data governance arrangements and genomic biobanks, is needed. New value-based payment models, upskilling of human resources, and national clinical guidelines need to be fostered to drive adoption. Conclusion: MoH is the indispensable conductor of health innovation. Through adopting a pro-reform, integrated stewardship strategy, MoHs can unlock the power of AI, genomics, and DTx to build more equitable, efficient, and resilient health systems, ultimately to speed progress towards Universal Health Coverage.

Institutions

Publication Details

Journal
Saudi Journal of Medicine and Public Health
Published
2024-12-31
DOI
https://doi.org/10.64483/jmph-119
Primary Topic
Artificial Intelligence in Healthcare and Education
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Fostering a Culture of Health Innovation: A Review of Regulation and Integration of AI, Genomics, and Digital Therapeutics by the Ministry of Health

Saudi Journal of Medicine and Public Health
Artificial Intelligence in Healthcare and Education
article

Fostering a Culture of Health Innovation: A Review of Regulation and Integration of AI, Genomics, and Digital Therapeutics by the Ministry of Health

article en

Abstract

Background: The global health landscape is being redefined by a new era of emerging technologies, including artificial intelligence (AI), genomics, and digital therapeutics (DTx). The technologies hold the promise to shift healthcare from an episodic, reactive, and hospital-based system to a predictive, personalized, and participatory system. However, their incorporation in healthcare systems raises severe problems for regulation, ethics, equity, and implementation. The national Ministry of Health (MoH) is at the center of coordinating this transition, but its role must change beyond traditional roles such that it actively encourages a culture of responsible innovation. Aim: The purpose of this narrative review is to synthesize existing literature for critically analyzing the multidimensional role of the MoH in spearheading the integration of AI, genomics, and DTx. Methods: Systematic peer-reviewed and grey literature search between 2010-2024 on PubMed, Scopus, Web of Science, and WHO, FDA, and other regulatory sources. Thematic analysis with results structured around three core domains: governance, infrastructure, and adoption. Results: The review suggests that holistic strategies are necessary for successful integration. In regulation, MoHs must implement flexible, risk-appropriate regulatory frameworks for adaptive AI and DTx that ensure ethical exploitation of genomic information. State investment in underlying infrastructure, such as national data governance arrangements and genomic biobanks, is needed. New value-based payment models, upskilling of human resources, and national clinical guidelines need to be fostered to drive adoption. Conclusion: MoH is the indispensable conductor of health innovation. Through adopting a pro-reform, integrated stewardship strategy, MoHs can unlock the power of AI, genomics, and DTx to build more equitable, efficient, and resilient health systems, ultimately to speed progress towards Universal Health Coverage.

Saudi Journal of Medicine and Public HealthVol. 1(1)
Ministry of Health (MY), Buraydah Colleges (SA), Primary HealthCare (MT), Ministry of Health (KW), Ministry of Health (BB), Ministry of Health (MM), Ministry of Health (JM)
Industry, innovation and infrastructure
Openalex Percentile: Top 58%
Artificial Intelligence in Healthcare and Education
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.